Option chain shows key data for Dynatronics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Dynatronics.

Dynatronics (OTC:DYNT) Stock, Option Chain

Dynatronics

Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables, and equipment, as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. It offers customers a one-stop shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and related supplies.

Movers

News

Intraday Update

Markets

Trading Ideas

ARHS

BENF

CJET

CLDI

CLEU

DYNT

GRFS

HLVX

IDYA

INTC

IONM

JEWL

KOSS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MORF

MYNZ

NEGG

NKLA

OPTT

PARAA

PLSE

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RYDE

SEDG

SHPW

SIRI

SLRN

SVMH

UXIN

VIVK

VRPX

WETH

ZAPP

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

nasdaq shutter

Equities

Pre-Market Outlook

General

The transition will not necessitate any action from shareholders, and the ticker symbol and CUSIP number for Dynatronics&#39; common stock will remain the same.

This Health-Tech Stock Jumps 40% In Pre-Market A Day Ahead Of Nasdaq Delisting And Transition To OTC

movers image

SFIX

Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Dynatronics Corp

DynTek, Inc. Com

Shares of Arhaus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>) fell sharply <a href="https://www.benzinga.com/quote/ARHS/analyst-ratings">during Monday's session</a>.
Jefferies analyst Jonathan Matuszewski downgraded Arhaus from Buy to Hold and lowered the price target from $22 to $16.
Arhaus shares dipped 7.9% to $14.55 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Morphic Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORF#NASDAQ">MORF</a>) shares jumped 75% to $55.72 after Eli Lilly agreed to buy the company for $57 per share in cash.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) climbed 71% to $6.97 after jumping around 50% on Friday.</li>
<li>SRIVARU Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) shares climbed 61.3% to $0.2549 after the company announced the deployment of advanced AI tools to manage its lead generation platform.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares climbed 47% to $2.1928 after gaining 8% on Friday.</li>
<li>Hywin Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYW#NASDAQ">HYW</a>) gained 39.5% to $0.4352.</li>
<li>Shapeways Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPW#NASDAQ">SHPW</a>) climbed 39% to $0.2918 after dipping 22% on Friday.</li>
<li>Myomo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYO#NYSE">MYO</a>) gained 32% to $3.80 after the company issued preliminary second-quarter revenue guidance above estimates.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) shares rose 31% to $0.3129 after jumping over 38% on Friday.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) climbed 31% to $0.7660 after the company closed a $2.5 million secured loan financing from an institutional investor, enabling the final payment of its litigation settlement.</li>
<li>LL Flooring Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LL#NYSE">LL</a>) surged 20.4% to $0.6789.</li>
<li>Nikola Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) rose 18.5% to $10.65.</li>
<li>Grifols, S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRFS#NASDAQ">GRFS</a>) gained 17.2% to $8.24 after Brookfield confirmed it held exploratory discussions with certain shareholders of the company in relation to a potential joint offer for Grifols&#8217; shares.</li>
<li>Pulse Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLSE#NASDAQ">PLSE</a>) gained 17.2% to $14.13 after the company announced it received the Breakthrough Device Designation from the FDA for its Cardiac Surgery System for the ablation of cardiac tissue for the treatment of atrial fibrillation.</li>
<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) climbed 16% to $1.23. Newegg Commerce said the Presale for its tenth annual FantasTech Sales event is now live.</li>
<li>Ocean Power Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NASDAQ">OPTT</a>) rose 16% to $0.4164 after the company signed a reseller agreement with Survey Equipment Services focused on the provision of OPT&#8217;s unmanned surface vehicles in the US.</li>
<li>Mainz Biomed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) gained 16% to $0.45.</li>
<li>R1 RCM Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCM#NASDAQ">RCM</a>) shares climbed 14.2% to $12.52.</li>
<li>Acelyrin, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRN#NASDAQ">SLRN</a>) gained 13.6% to $4.60.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) shares gained 12.3% to $31.89 after surging 20% on Friday.</li>
<li>IDEAYA Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) shares gained 12.1% to $38.41 after the company announced interim Phase 2 monotherapy expansion data for IDE397 in MTAP-deletion urothelial and lung cancer. Additionally, Mizuho initiated coverage on the stock with an Outperform rating.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) rose 11.3% to $27.88 after B of A Securities upgraded the stock from Underperform to Neutral.</li>
<li>Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) gained 9.4% to $42.05 after the company increased its second-quarter core sales guidance.</li>
<li>Dynatronics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) shares rose 8.6% to $0.2310 after declining around 8% on Friday.</li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>) rose 4.6% to $21.41. Paramount Global and Skydance Media inked a definitive agreement to create a new entity, "New Paramount," in a $28 billion merger deal.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) gained 3.8% to $33.26. Intel has bypassed Vietnam for a substantial investment project, citing insufficient investment incentives.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>HilleVax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLVX#NASDAQ">HLVX</a>) shares dipped 86.7% to $1.87 after the company announced the NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants.</li>
<li>Adamas One Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JEWL#NASDAQ">JEWL</a>) shares dipped 83% to $0.3360 after dipping over 20% on Friday.</li>
<li>China Liberal Education Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares fell 66.4% to $0.7303 after dipping 24% on Friday.</li>
<li>SYLA Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYT#NASDAQ">SYT</a>) fell 31.1% to $2.0950.</li>
<li>Chijet Motor Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJET#NASDAQ">CJET</a>) dipped 28.4% to $5.80.</li>
<li>Ryde Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NASDAQ">RYDE</a>) declined 22.8% to $6.33.</li>
<li>Koss Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) fell 21% to $10.55.</li>
<li>Wetouch Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) fell 19.5% to $2.57. Wetouch Technologies announced a $15 million stock buyback program to repurchase common stock.</li>
<li>Calidi Biotherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#NYSE">CLDI</a>) declined 19.4% to $0.16</li>
<li>Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) shares fell 15.2% to $4.1050. Beneficient said it will release its fourth quarter financial results before the opening bell on Tuesday, July 9.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) shares fell 15.1% to $18.77.</li>
<li>Vivakor inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIVK#NASDAQ">VIVK</a>) shares fell 15% to $1.97.</li>
<li>Inventiva S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NYSE">IVA</a>) shares fell 12% to $2.6050 after the company issued an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position.</li>
<li>Uxin Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) dipped 11.3% to $1.77 after the company announced a partnership with Zhengzhou Airport Industry for the launch of a new used car superstore.</li>
<li>Sirius XM Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) fell 10.7% to $3.3099.</li>
<li>The Greenbrier Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) dipped 10.6% to $43.37 after the company reported worse-than-expected quarterly financial results.</li>
<li>Qualigen Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) shares declined 7.2% to $0.2599 after jumping 60% on Friday.</li>
<li>Assure Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONM#NASDAQ">IONM</a>) fell 7% to $0.2943.</li>
<li>Zuora, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZUO#NYSE">ZUO</a>) fell 5.6% to $9.02. Craig-Hallum analyst Chad Bennett downgraded Zuora from Buy to Hold and lowered the price target from $12 to $10.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/07/39667298/this-dominos-analyst-turns-bullish-here-are-top-5-upgrades-for-monday">This Domino&#8217;s Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday</a>

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

In a significant development, Dynatronics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) experienced a pre-market surge of 40% on Monday. This comes just a day before it transitions to the OTCQB Venture Market, following its delisting from Nasdaq.
What Happened: Dynatronics&#8217; stock was trading at $0.2982, marking a significant rise from its Friday close of $0.2120. The company, a leading manufacturer of physical therapy and rehabilitation products, is set to be delisted from Nasdaq due to its inability to meet the minimum bid price requirement.
The Nasdaq delisting will come into effect at the market open on July 9. Subsequently, Dynatronics&#8217; common stock will commence trading on the OTCQB Venture Market. The transition will not necessitate any action from shareholders, and the ticker symbol and CUSIP number for Dynatronics&#8217; common stock will remain the same.
See Also: <a href="https://www.benzinga.com/partner/emerging-markets/24/07/39573400/the-benefits-of-cash-settled-options?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">The Benefits Of Cash-Settled Options</a>
Despite the change in market listing, Dynatronics will carry on with its operations as usual. It will continue to be a reporting company under the Securities Exchange Act of 1934. The company&#8217;s product range, which is widely used in physical therapy, rehabilitation, orthopedics, pain management, and athletic training, will continue to be marketed to a diverse customer base.
The move to the OTCQB is part of Dynatronics&#8217; strategic response to the recurring issue of noncompliance with Nasdaq&#8217;s listing requirements, as per a company press release statement.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39655253/robert-f-kennedy-jr-stirs-controversy-by-promising-to-open-the-files-on-pivotal-moment-in-us-his?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Robert F. Kennedy Jr. Stirs Controversy By Promising To &#8216;Open The Files&#8217; On Pivotal Moment In US History</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Shares of Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>) rose sharply in <a href="https://www.benzinga.com/general/entertainment/24/07/39658163/paramount-board-endorses-merger-with-skydance-media-as-david-ellison-nears-acquisition-of-m">today's pre-market trading</a>.
Paramount Global and Skydance Media inked a definitive agreement to create a new entity, "New Paramount," in a $28 billion merger deal.
Paramount Global shares jumped 7.5% to $22.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Shapeways Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPW#NASDAQ">SHPW</a>) rose 93.7% to $0.4068 in pre-market trading after dipping 22% on Friday.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares rose 52.3% to $2.27 in pre-market trading after gaining 8% on Friday.</li>
<li>Dynatronics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) shares rose 36.6% to $0.29 in pre-market trading after declining around 8% on Friday.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) gained 27% to $5.17 in pre-market trading after jumping around 50% on Friday.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) shares rose 24.8% to $0.2997 in pre-market trading after jumping over 38% on Friday.</li>
<li>Grifols, S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRFS#NASDAQ">GRFS</a>) rose 22.9% to $8.65 in pre-market trading. Grifols shares gained around 6% on Friday after the company appointed Rahul Srinivasan as CFO, effective Sept. 16.</li>
<li>IDEAYA Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) shares gained 17.8% to $40.37 in pre-market trading. IDEAYA will present clinical data update for IDE397 Phase 2 monotherapy expansion dose in MTAP-deletion urothelial and lung cancer on July 8, 2024.</li>
<li>R1 RCM Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCM#NASDAQ">RCM</a>) shares climbed 13.2% to $12.39 in pre-market trading.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) shares gained 10.9% to $31.50 in pre-market trading after surging 20% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>China Liberal Education Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares fell 21.6% to $1.71 in pre-market trading after dipping 24% on Friday.</li>
<li>Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) shares fell 15.1% to $4.11 in pre-market trading. Beneficient said it will release its fourth quarter financial results before the opening bell on Tuesday, July 9.</li>
<li>Qualigen Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) shares declined 14.1% to $0.2408 in pre-market trading after jumping 60% on Friday.</li>
<li>Inventiva S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NYSE">IVA</a>) shares fell 13.8% to $2.55 in pre-market trading after the company issued an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position.</li>
<li>Assure Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONM#NASDAQ">IONM</a>) fell 13.3% to $0.2740 in pre-market trading.</li>
<li>Adamas One Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JEWL#NASDAQ">JEWL</a>) shares dipped 12.3% to $0.32 in pre-market trading after dipping over 20% on Friday.</li>
<li>Vivakor inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIVK#NASDAQ">VIVK</a>) shares fell 11.6% to $2.05 in pre-market trading.</li>
<li>A2Z Smart Technologies Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZ#NASDAQ">AZ</a>) shares declined 11.5% to $0.38 in pre-market trading after gaining around 11% on Friday.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) shares fell 6.4% to $20.70 in pre-market trading.</li>
<li>Stitch Fix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) fell 5.3% to $3.95 in pre-market trading after gaining over 7% on Friday</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39646161/top-3-financial-stocks-youll-regret-missing-in-q3">Top 3 Financial Stocks You&#8217;ll Regret Missing In Q3</a>

<h3>Gainers</h3>
<ul>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock rose 14.74% to $0.4. The company's market cap stands at $2.1 million. </li>
<li>Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) shares moved upwards by 10.8% to $0.45. The market value of their outstanding shares is at $33.5 million. </li>
<li>SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) stock rose 8.94% to $2.8. The market value of their outstanding shares is at $25.8 million. </li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) shares moved upwards by 8.04% to $1.61. The company's market cap stands at $1.7 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares increased by 7.17% to $0.61. The market value of their outstanding shares is at $1.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock fell 9.9% to $0.12 during Tuesday's after-market session. The company's market cap stands at $3.8 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock declined by 9.53% to $2.47. The market value of their outstanding shares is at $13.3 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock decreased by 8.5% to $3.88. The market value of their outstanding shares is at $3.8 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock decreased by 8.19% to $0.36. The company's market cap stands at $11.4 million. </li>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) stock decreased by 7.86% to $0.36. The company's market cap stands at $6.8 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares fell 7.82% to $0.52. The company's market cap stands at $3.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBLG

BIOL

ENSC

EVAX

RDHL

SABS

SBFM

SNGX

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock increased by 28.17% to $0.13. The market value of their outstanding shares is at $4.6 million. </li>
<li>NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) shares moved upwards by 27.0% to $0.15. The market value of their outstanding shares is at $5.7 million. </li>
<li>ZimVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIMV#NASDAQ">ZIMV</a>) shares moved upwards by 23.61% to $20.99. The company's market cap stands at $572.7 million. </li>
<li>Kintara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) stock moved upwards by 17.16% to $0.17. The market value of their outstanding shares is at $6.6 million. As per the press release, Q3 earnings came out 3 days ago. </li>
<li>Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) shares increased by 15.62% to $27.45. The company's market cap stands at $5.1 billion. The company's, Q4 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reneo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPHM#NASDAQ">RPHM</a>) stock fell 13.8% to $1.43 during Friday's pre-market session. The market value of their outstanding shares is at $47.8 million. </li>
<li>Lucy Scientific Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) shares fell 11.33% to $1.41. The company's market cap stands at $2.4 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares declined by 10.01% to $0.13. The market value of their outstanding shares is at $15.4 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) stock declined by 9.1% to $1.5. The market value of their outstanding shares is at $1.3 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) shares decreased by 8.43% to $0.4. The company's market cap stands at $2.1 million. </li>
<li>Protalix BioTherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLX#AMEX">PLX</a>) stock declined by 7.7% to $1.08. The company's market cap stands at $79.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKAN

ATNF

DOCS

Kintara Therapeutics, Inc. - Common Stock

KTRA

LSDI

RPHM

SCPX

SINT

ZIMV

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Lucy Scientific Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) stock moved upwards by 123.5% to $1.14 during Thursday's pre-market session. The market value of their outstanding shares is at $2.0 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) stock moved upwards by 19.67% to $0.15. The market value of their outstanding shares is at $18.7 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock increased by 16.7% to $0.51. The market value of their outstanding shares is at $2.7 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) shares moved upwards by 15.99% to $0.31. The company's market cap stands at $14.8 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) shares moved upwards by 15.5% to $0.12. The market value of their outstanding shares is at $4.5 million. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) stock increased by 13.36% to $0.65. The company's market cap stands at $125.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares declined by 13.6% to $0.92 during Thursday's pre-market session. The company's market cap stands at $46.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>NexImmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXI#NASDAQ">NEXI</a>) shares decreased by 12.27% to $3.04. The company's market cap stands at $4.1 million. </li>
<li>Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) stock declined by 10.9% to $4.66. The market value of their outstanding shares is at $235.3 million. </li>
<li>Pieris Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIRS#NASDAQ">PIRS</a>) stock decreased by 10.12% to $10.22. The company's market cap stands at $12.6 million. </li>
<li>Strata Skin Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSKN#NASDAQ">SSKN</a>) stock decreased by 9.29% to $0.38. The market value of their outstanding shares is at $13.3 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>SCWorx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) shares declined by 8.55% to $2.14. The company's market cap stands at $2.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DBVT

EYEN

GLUE

NEXI

OTRK

PIRS

SSKN

WORX

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) stock moved upwards by 143.1% to $0.13 during Wednesday's pre-market session. The company's market cap stands at $16.4 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Arcutis Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQT#NASDAQ">ARQT</a>) stock increased by 18.92% to $9.67. The market value of their outstanding shares is at $1.1 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>MultiPlan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) stock increased by 17.24% to $0.66. The market value of their outstanding shares is at $426.5 million. </li>
<li>CASI Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASI#NASDAQ">CASI</a>) shares moved upwards by 15.45% to $3.66. The company's market cap stands at $49.0 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) shares increased by 15.11% to $0.47. The market value of their outstanding shares is at $2.2 million. As per the news, the Q3 earnings report came out 4 days ago. </li>
<li>Virios Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRI#NASDAQ">VIRI</a>) stock rose 14.4% to $0.44. The market value of their outstanding shares is at $8.4 million. The company's, Q1 earnings came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock decreased by 60.5% to $0.91 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Bolt Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLT#NASDAQ">BOLT</a>) stock decreased by 29.56% to $0.93. The market value of their outstanding shares is at $35.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) stock decreased by 19.29% to $1.59. The market value of their outstanding shares is at $3.6 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Vivos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) stock fell 18.48% to $2.03. The market value of their outstanding shares is at $6.0 million. The company's, Q1 earnings came out yesterday. </li>
<li>Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) stock decreased by 17.78% to $0.7. The market value of their outstanding shares is at $1.8 million. </li>
<li>Vicarious Surgical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBOT#NYSE">RBOT</a>) stock declined by 13.45% to $0.29. The market value of their outstanding shares is at $42.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEMD

ARQT

BOLT

CASI

MPLN

RBOT

TCON

VIRI

VVOS

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) stock rose 55.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $251.8 million. </li>
<li>MiNK Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) stock increased by 31.09% to $1.18. The company's market cap stands at $40.9 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock increased by 21.69% to $0.57. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings came out 2 days ago. </li>
<li>Tarsus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) shares moved upwards by 18.08% to $43.69. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) shares increased by 15.07% to $1.45. The company's market cap stands at $23.3 million. </li>
<li>Fulcrum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) shares rose 13.78% to $8.5. The market value of their outstanding shares is at $528.3 million. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock declined by 13.1% to $3.0 during Monday's pre-market session. The market value of their outstanding shares is at $2.5 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares declined by 12.81% to $0.22. The market value of their outstanding shares is at $4.3 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock fell 12.06% to $1.24. The market value of their outstanding shares is at $7.5 million. </li>
<li>Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) stock fell 9.09% to $30.03. The company's market cap stands at $2.6 billion. The company's, Q1 earnings came out today. </li>
<li>NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) shares declined by 9.08% to $0.07. The company's market cap stands at $2.6 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) stock decreased by 8.89% to $0.2. The market value of their outstanding shares is at $2.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APDN

CCLD

FTRE

FULC

INKT

PRTG

RNAZ

SXTP

TARS

TVGN

12 Health Care Stocks Moving In Monday's Pre-Market Session

The guidance cut reflects&nbsp;slower demand in the rehabilitation space and changes to our private label customer relationships. We are not providing gross margin guidance currently. Given our reductions in revenue expectations, we are seeking improved stabilization in the business before considering reinstituting such guidance. SG&amp;A is anticipated to be in the range of 30% to 32% of net sales for the fiscal year.

Guidance

Dynatronics Lowered FY24 Net Sales Outlook To $32.5M-$34M (From $34M-$37M Prior), Vs Est. $34.2M

Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.26) by 34.62 percent. The company reported quarterly sales of $7.658 million which missed the analyst consensus estimate of $7.800 million by 1.82 percent. This is a 17.08 percent decrease over sales of $9.235 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Dynatronics Q3 2024 GAAP EPS $(0.17) Beats $(0.26) Estimate, Sales $7.658M Miss $7.800M Estimate

<h3>Gainers</h3>
<ul>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares moved upwards by 39.41% to $0.05. The company's market cap stands at $6.3 million. </li>
<li>23andMe Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) stock moved upwards by 26.61% to $0.45. The company's market cap stands at $217.7 million. </li>
<li>Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) shares rose 25.62% to $6.03. The company's market cap stands at $15.6 million. </li>
<li>Trevena (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) stock moved upwards by 22.86% to $0.49. The company's market cap stands at $9.0 million. </li>
<li>Citius Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) stock moved upwards by 16.38% to $0.95. The company's market cap stands at $151.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares declined by 22.5% to $3.24 during Thursday's pre-market session. The company's market cap stands at $31.0 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock decreased by 17.61% to $0.42. The market value of their outstanding shares is at $4.4 million. </li>
<li>Sonoma Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) stock declined by 13.75% to $0.14. The company's market cap stands at $2.2 million. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares fell 11.12% to $0.34. The company's market cap stands at $3.5 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock fell 10.26% to $0.53. The market value of their outstanding shares is at $2.5 million. </li>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares decreased by 9.46% to $0.63. The company's market cap stands at $47.7 million. As per the press release, Q4 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNTC

BPTH

CTXR

MBIO

NRXP

SNOA

TRVN

Shares of The Travelers Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trv#NYSE">TRV</a>) fell sharply during Wednesday&rsquo;s session following first-quarter earnings.
Travelers reported a mixed first quarter, with earnings lagging analyst&#39; expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier.
Travelers shares dipped 8.1% to $205.03 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) jumped 53% to $0.0350.</li>
<li>VIA optronics AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/viao#NYSE">VIAO</a>) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday.</li>
<li>AERWINS Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awin#NASDAQ">AWIN</a>) jumped 42.2% to $4.70.</li>
<li>The Children&#39;s Place, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plce#NASDAQ">PLCE</a>) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider.</li>
<li>EZGO Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezgo#NASDAQ">EZGO</a>) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) rose 19.6% to $2.0461.</li>
<li>WiSA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wisa#NASDAQ">WISA</a>) gained 19% to $7.32 on continued upward momentum after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand.</li>
<li>Viracta Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virx#NASDAQ">VIRX</a>) climbed 19% to $0.8501. Oppenheimer analyst Hartaj Singh maintained Viracta Therapeutics with an Outperform and maintained a $13 price target.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) rose 17.5% to $0.94 after the company announced that it signed a distribution partnership agreement with a Fortune 1000 Energy Company.</li>
<li>Rani Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rani#NASDAQ">RANI</a>) jumped 14.4% to $7.86.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgem#NASDAQ">CGEM</a>) gained 14% to $19.75. HC Wainwright &amp; Co. analyst Edward White maintained Cullinan Oncology with a Buy and lowered the price target from $34 to $29.</li>
<li>United Airlines Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ual#NASDAQ">UAL</a>) rose 11.2% to $46.12 after the company reported better-than-expected first-quarter financial results.</li>
<li>Chromocell Therapeutics Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chro#NYSE">CHRO</a>) gained 11.8% to $2.0356 after falling around 7% on Tuesday.</li>
<li>ALX Oncology Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alxo#NASDAQ">ALXO</a>) rose 10.4% to $16.01.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) gained 7.5% to $2.9250, bouncing back from the selling pressure the stock has faced in recent week.</li>
<li>Interactive Brokers Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibkr#NASDAQ">IBKR</a>) rose 5.2% to $112.93 following upbeat quarterly earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>ICZOOM Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izm#NASDAQ">IZM</a>) shares dipped 87.8% to $6.19.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) fell 47% to $3.5879.</li>
<li>Trio Petroleum Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpet#NYSE">TPET</a>) fell 35.8% to $0.3144 after dipping over 22% on Tuesday.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) dipped 31% to $2.43 after the company announced the exercise of warrants for $6.2 million in gross proceeds.</li>
<li>iSun, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isun#NASDAQ">ISUN</a>) declined 27% to $0.1556.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) fell 25.7% to $1.2001. China SXT Pharmaceuticals shares jumped 38% on Tuesday following a post on X from trader Zack Morris mentioning the stock.</li>
<li>Portage Biotech Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) fell 25.3% to $0.21. The company recently announced that it is expanding its evaluation of strategic alternatives and implementing additional measures to extend its available cash runway.</li>
<li>Trilogy Metals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmq#NYSE">TMQ</a>) shares fell 23.2% to $0.3865.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) dipped 22.6% to $1.44.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) fell 22% to $33.83 after gaining around 18% on Tuesday.</li>
<li>Finch Therapeutics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnch#NASDAQ">FNCH</a>) dipped 21.9% to $2.42.</li>
<li>Sage Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sage#NASDAQ">SAGE</a>) shares fell 20.8% to $12.37. The company announced topline results from Phase 2 PRECEDENT study of dalzanemdor for the treatment of people with mild cognitive impairment in Parkinson&#39;s Disease.</li>
<li>Ontrak, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otrk#NASDAQ">OTRK</a>) fell 20.3% to $0.3666 after the company reported worse-than-expected quarterly financial results.</li>
<li>SolarMax Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) dipped 20% to $9.72 following fiscal year 2023 results.</li>
<li>Dragonfly Energy Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfli#NASDAQ">DFLI</a>) declined 15.8% to $0.5199. Dragonfly Energy shares jumped over 36% on Tuesday after the company reported better-than-expected fourth-quarter EPS results.</li>
<li>Montrose Environmental Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/meg#NYSE">MEG</a>) fell 13.3% to $36.37 after announcing a public offering of 3 million shares.</li>
<li>Dynatronics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dynt#NASDAQ">DYNT</a>) fell 12.2% to $0.50 after gaining around 48% on Tuesday.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 12% to $2.70 following first-quarter earnings.</li>
<li>Adaptive Biotechnologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adpt#NASDAQ">ADPT</a>) declined 9.3% to $2.4950.</li>
<li>SNDL Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) fell 9.3% to $1.7950.</li>
<li>Arm Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arm#NASDAQ">ARM</a>) fell 9.3% to $110.65.</li>
<li>J B Hunt Transport Services Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jbht#NASDAQ">JBHT</a>) shares fell 9.2% to $166.25 after the company missed first-quarter revenue and EPS estimates.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) dipped 8.8% to $1,143.81. MicroStrategy is expected to report its financial results for the first quarter of 2024 after the closing bell on April 29, 2024.</li>
<li>Forward Air Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwrd#NASDAQ">FWRD</a>) fell 8.3% to $23.13.</li>
<li>Autodesk, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adsk#NASDAQ">ADSK</a>) fell 7.1% to $211.97 after the company announced that it will not file its Annual Report on Form 10-K for the year ended Jan. 31, 2024 within the 15-day extension period. The company provided an update on the previously reported internal investigation that is currently being conducted by the Audit Committee.</li>
<li>ASML Holding N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asml#NASDAQ">ASML</a>) shares declined 7.2% to $907.11 after the company reported worse-than-expected first-quarter results and issued second-quarter guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38293462/discover-financial-gears-up-for-q1-print-these-most-accurate-analysts-revise-forecasts-ahead-of-ear"> Discover Financial Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Penny Stocks

Small Cap

ADPT

ADSK

ALXO

ASML

AWIN

CGEM

CHRO

CXAI

DFLI

DXYZ

EDBL

EZGO

FNCH

FWRD

HUBC

IBKR

INVO

ISUN

JBHT

LGVN

MSTR

PLCE

RANI

SAGE

SMXT

SNDL

SPEC

SXTC

TPET

VIAO

VIRX

VNDA

WISA

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>INVO Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares moved upwards by 40.8% to $0.44. The market value of their outstanding shares is at $56.0 million. </li>
<li>Galera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) shares moved upwards by 31.76% to $0.22. The market value of their outstanding shares is at $12.1 million. </li>
<li>Vanda Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNDA#NASDAQ">VNDA</a>) stock moved upwards by 26.91% to $5.14. The company's market cap stands at $295.7 million. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares moved upwards by 23.62% to $2.25. The market value of their outstanding shares is at $12.9 million. </li>
<li>BIMI Intl Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) shares moved upwards by 16.98% to $1.86. The company's market cap stands at $26.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) stock decreased by 19.4% to $12.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $757.3 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) stock declined by 17.81% to $0.38. The company's market cap stands at $16.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares declined by 17.29% to $1.34. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) shares decreased by 11.91% to $0.48. The company's market cap stands at $2.3 million. </li>
<li>Etao International Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETAO#NASDAQ">ETAO</a>) shares declined by 11.89% to $3.3. The market value of their outstanding shares is at $16.9 million. </li>
<li>Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) shares declined by 10.96% to $11.46. The market value of their outstanding shares is at $79.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIMI

CLNN

DTIL

ETAO

GRTX

Shares of INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) rose sharply in today&rsquo;s pre-market trading after reporting <a href="https://www.benzinga.com/quote/INVO/earnings">fourth-quarter results.</a>
The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Mobile Global Esports Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgam#NASDAQ">MGAM</a>) shares gained 36.1% to $0.1565 in pre-market trading after falling around 9% on Tuesday. On April 16, Maxim Group analyst Jack Vander Aarde downgraded Mobile Global Esports from Buy to Hold.</li>
<li>Chromocell Therapeutics Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chro#NYSE">CHRO</a>) gained 29.1% to $2.35 in pre-market trading after falling around 7% on Tuesday.</li>
<li>Clene Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clnn#NASDAQ">CLNN</a>) gained 27.9% to $0.3965 in pre-market trading after the company announced Phase 2 VISIONARY-MS long term extension study results at the 2024 American Academy of Neurology Annual Meeting.</li>
<li>VIA optronics AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/viao#NYSE">VIAO</a>) shares gained 27.4% to $0.3316 in pre-market trading after dipping over 15% on Tuesday.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) shares rose 22.3% to $4.78 in pre-market trading after the company announced 24% ARR growth in 2023.</li>
<li>Gamer Pakistan Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gpak#NASDAQ">GPAK</a>) shares gained 21.1% to $0.34 in pre-market trading after gaining 11% on Tuesday.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) shares gained 19.5% to $2.57 in pre-market trading after gaining 10% on Tuesday.</li>
<li>ICZOOM Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izm#NASDAQ">IZM</a>) rose 19% to $60.69 in today&rsquo;s pre-market trading.</li>
<li>Pacific Biosciences of California, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) gained 12.1% to $1.57 in pre-market trading. PacBio shares dipped more than 50% on Tuesday after the company issued weak guidance.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Connexa Sports Technologies Inc. (NASDAQ: YYAO) fell 32.3% to $1.42 in pre-market trading.</li>
<li>Dynatronics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dynt#NASDAQ">DYNT</a>) fell 19.2% to $0.4442 in pre-market trading after gaining around 48% on Tuesday.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) fell 17.3% to $35.97 in pre-market trading after gaining around 18% on Tuesday.</li>
<li>WiSA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wisa#NASDAQ">WISA</a>) fell 15.2% to $5.17 in pre-market trading. WiSA shares jumped over 248% on Tuesday after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand.</li>
<li>Dragonfly Energy Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfli#NASDAQ">DFLI</a>) declined 14.8% to $0.5232 in pre-market trading. Dragonfly Energy shares jumped over 36% on Tuesday after the company reported better-than-expected fourth-quarter EPS results.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) fell 14.7% to $1.38 pre-market trading. China SXT Pharmaceuticals shares jumped 38% on Tuesday following a post on X from trader Zack Morris mentioning the stock.</li>
<li>Trilogy Metals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmq#NYSE">TMQ</a>) shares fell 14.4% to $0.43 in pre-market trading.</li>
<li>Trio Petroleum Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpet#NYSE">TPET</a>) fell 12.8% to $0.4250 pre-market trading after dipping over 22% on Tuesday.</li>
<li>J B Hunt Transport Services Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jbht#NASDAQ">JBHT</a>) shares fell 6% to $172.00 in pre-market trading after the company missed first-quarter revenue and EPS estimates.</li>
<li>ASML Holding N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asml#NASDAQ">ASML</a>) shares declined 4.9% to $929.00 in pre-market trading after the company reported worse-than-expected first-quarter results and issued second-quarter guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38284995/investor-optimism-decreases-dow-ends-6-session-losing-streak"> Investor Optimism Decreases; Dow Ends 6-Session Losing Streak</a>
&nbsp;

GPAK

MGAM

PACB

Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) shares moved upwards by 11.65% to $1.15. The company's market cap stands at $19.5 million. </li>
<li>Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) stock moved upwards by 8.22% to $2.5. The market value of their outstanding shares is at $32.2 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock increased by 7.14% to $1.8. The market value of their outstanding shares is at $2.3 million. </li>
<li>IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) shares rose 6.99% to $0.52. The company's market cap stands at $34.3 million. </li>
<li>SHL Telemedicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLT#NASDAQ">SHLT</a>) stock increased by 6.94% to $5.39. The market value of their outstanding shares is at $88.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares fell 15.9% to $0.31 during Tuesday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock decreased by 14.53% to $0.47. The market value of their outstanding shares is at $2.2 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) stock decreased by 13.29% to $0.4. The market value of their outstanding shares is at $16.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock fell 12.35% to $1.42. </li>
<li>PaxMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXMD#NASDAQ">PXMD</a>) shares fell 9.75% to $0.6. The market value of their outstanding shares is at $4.4 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock declined by 9.35% to $3.2. The company's market cap stands at $10.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CYCC

LEXX

PXMD

SHLT

TBIO

TLPH

Shares of Skillsoft Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skil#NASDAQ">SKIL</a>) fell sharply during Tuesday&rsquo;s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company&rsquo;s quarterly sales came in at $137.540 million versus expectations of $141.897 million.
Skillsoft shares dipped 26.7% to $6.74 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>WiSA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wisa#NASDAQ">WISA</a>) jumped 85% to $3.2379 after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand.</li>
<li>Palisade Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pali#NASDAQ">PALI</a>) shares climbed 79.1% to $7.45 after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108.</li>
<li>Jaguar Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) shares gained 67% to $0.1989 after the company signed an exclusive 5-year in-license agreement with Venture Life Group for Gelclair.</li>
<li>Dynatronics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dynt#NASDAQ">DYNT</a>) shares rose 44.4% to $0.5342 after dipping over 5% on Monday.</li>
<li>IMAC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/back#NASDAQ">BACK</a>) surged 40% to $4.69.</li>
<li>Peraso Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prso#NASDAQ">PRSO</a>) gained 38.8% to $1.75. Peraso recently announced that it received an additional $2.88 million purchase order.</li>
<li>Macatawa Bank Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcbc#NASDAQ">MCBC</a>) rose 38.8% to $13.78 after Wintrust Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wftc#NASDAQ">WFTC</a>) and Macatawa Bank announced that they have entered into a definitive merger agreement for Wintrust to acquire Macatawa in an all-stock transaction.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) jumped 29.9% to $1.52.</li>
<li>Dragonfly Energy Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfli#NASDAQ">DFLI</a>) gained 26.7% to $0.57 after the company posted a profit for the fourth quarter.</li>
<li>Intra-Cellular Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itci#NASDAQ">ITCI</a>) gained 24.1% to $80.39 after the company announced Lumateperone 42 mg once daily as adjunctive therapy to antidepressants met its primary endpoint.</li>
<li>Cullinan Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgem#NASDAQ">CGEM</a>) jumped 20.4% to $19.93. The company announced its plan to expand into autoimmune diseases.</li>
<li>Taoping Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/taop#NASDAQ">TAOP</a>) shares gained 14.1% to $0.97 after dipping 20% on Monday.</li>
<li>BioSig Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsgm#NASDAQ">BSGM</a>) climbed 13.1% to $1.2439.</li>
<li>NextNav Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nn#NASDAQ">NN</a>) gained 13.1% to $7.98.</li>
<li>UnitedHealth Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>) jumped 6.2% to $473.20 following better-than-expected first-quarter earnings.</li>
<li>Contineum Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctnm#NASDAQ">CTNM</a>) gained 6.1% to $15.50.</li>
<li>Telefonaktiebolaget LM Ericsson (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eric#NASDAQ">ERIC</a>) rose 4.7% to $5.01 after the company reported better-than-expected first-quarter EPS results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) shares dipped 58.2% to $0.2947 after the company announced a short-term shareholder rights plan and a new equity investment.</li>
<li>Calidi Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cldi#NASDAQ">CLDI</a>) fell 54.8% to $0.2711 after the company announced the pricing of a $6.1 million public offering.</li>
<li>Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) fell 46% to $1.07.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) fell 40.2% to $1.6999 after the company issued weak guidance.</li>
<li>Ryvyl Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvyl#NASDAQ">RVYL</a>) fell 29.3% to $1.44 after the company announced the launch of a proposed underwritten public offering.</li>
<li>Beneficient (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/benf#NASDAQ">BENF</a>) dipped 25% to $0.0676. Beneficient announced a reverse stock split to regain compliance with Nasdaq&#39;s minimum bid price.</li>
<li>PainReform Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prfx#NASDAQ">PRFX</a>) fell 23.3% to $0.7515 after the company priced its $4 million public offering.</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) dipped 23.3% to $2.46. Siyata Mobile filed for offering of maximum of $4 million of common shares.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kavl#NASDAQ">KAVL</a>) fell 22.2% to $4.90.</li>
<li>ParaZero Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/przo#NASDAQ">PRZO</a>) fell 18% to $0.91 after the company announced its intention to enter the counter unmanned aircraft system market.</li>
<li>Complete Solaria, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cslr#NASDAQ">CSLR</a>) dipped 16.5% to $0.2167.</li>
<li>SolarMax Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) fell 13.4% to $12.91.</li>
<li>Addex Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxn#NASDAQ">ADXN</a>) declined 10.8% to $22.07 after falling around 3% on Monday.</li>
<li>Inovio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ino#NASDAQ">INO</a>) shares declined 10.3% to $9.87. INOVIO priced its $36 million underwritten offering of 2,536,258 common stock at $7.693 per share.</li>
<li>First Majestic Silver Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ag#NYSE">AG</a>) fell 10.2% to $6.72.</li>
<li>SciSparc Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprc#NASDAQ">SPRC</a>) fell 10.1% to $1.33 after declining around 6% on Monday. The company recently announced the acquisition of AutoMax.</li>
<li>Qilian International Holding Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qli#NASDAQ">QLI</a>) fell 9.1% to $0.6303 after declining around 8% on Monday.</li>
<li>ProFrac Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acdc#NASDAQ">ACDC</a>) fell 8.6% to $7.76.</li>
<li>Adlai Nortye Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anl#NYSE">ANL</a>) declined 7.4% to $9.80.</li>
<li>Cartesian Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnac#NASDAQ">RNAC</a>) fell 6.9% to $17.69.</li>
<li>MINISO Group Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NASDAQ">MNSO</a>) fell 6.8% to $19.33.</li>
<li>ArcelorMittal SA (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mt#NYSE">MT</a>) shares fell 6.6% to $25.16 after Deutsche Bank downgraded the stock from Buy to Hold.</li>
<li>Live Nation Entertainment, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lyv#NYSE">LYV</a>) fell 5.8% to $94.00 following a report indicating the Justice Department will file an antitrust lawsuit against the company.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38271269/dow-gains-over-100-points-bank-of-america-posts-upbeat-profit"> Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit</a>

ACDC

ADXN

BACK

BNED

BSGM

CSLR

CTNM

ERIC

ITCI

JAGX

KAVL

MCBC

MNSO

PALI

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Comments

Dynatronics

Dynatronics (DYNT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga